Canada· CA-DIN-02284413
ROTATEQ
A rotavirus, pentavalent, lebend, abgeschwächt product containing human-bovine rotavirus reassortant type g1 + human-bovine rotavirus reassortant type p1(8) + human-bovine rotavirus reassortant type g4 + human-bovine rotavirus reassortant type g2, registered in Canada by MERCK CANADA INC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Rotavirus, pentavalent, lebend, abgeschwächt is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BH02 (rotavirus, pentavalent, lebend, abgeschwächt), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Rotavirus, pentavalent, lebend, abgeschwächt · ATC J07BH02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 + HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1(8) + HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4 + HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2
- Manufacturer
- MERCK CANADA INC
- Country
- Canada (CA)
- ATC code
- J07BH02
- ATC class
- Rotavirus, pentavalent, lebend, abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BH02
Rotavirus, pentavalent, lebend, abgeschwächt, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa45e4d1-cf2c-4b17-85f0-329eb6c37efd GET /v1/drugs/fa45e4d1-cf2c-4b17-85f0-329eb6c37efd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02284413",
"form": "SOLUTION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07BH02",
"schedule": [
"Schedule D"
],
"drug_code": "76999",
"strengths": [
"2210000 UNIT",
"2290000 UNIT",
"2040000 UNIT",
"2840000 UNIT",
"2220000 UNIT"
],
"ahfs_class": null,
"substances": [
"HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1",
"HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1(8)",
"HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4",
"HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2",
"HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3"
],
"product_categorization": null
}See everything about rotavirus, pentavalent, lebend, abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.